A detailed history of Commonwealth Equity Services, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 91,321 shares of PACB stock, worth $160,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,321
Previous 12,790 614.0%
Holding current value
$160,724
Previous $18,000 761.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1.2 - $2.17 $94,237 - $170,412
78,531 Added 614.0%
91,321 $155,000
Q2 2024

Jul 31, 2024

SELL
$1.36 - $3.65 $1,468 - $3,942
-1,080 Reduced 7.79%
12,790 $18,000
Q1 2024

Apr 29, 2024

SELL
$3.52 - $9.59 $5,593 - $15,238
-1,589 Reduced 10.28%
13,870 $52,000
Q4 2023

Feb 06, 2024

SELL
$5.97 - $10.36 $2,710 - $4,703
-454 Reduced 2.85%
15,459 $152,000
Q3 2023

Oct 23, 2023

SELL
$8.23 - $13.93 $5,489 - $9,291
-667 Reduced 4.02%
15,913 $133,000
Q1 2023

May 11, 2023

SELL
$7.94 - $12.02 $1,468 - $2,223
-185 Reduced 1.1%
16,580 $192,000
Q4 2022

Feb 07, 2023

SELL
$5.67 - $11.2 $108,881 - $215,073
-19,203 Reduced 53.39%
16,765 $137,000
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $23,737 - $51,762
-6,040 Reduced 14.38%
35,968 $208,000
Q2 2022

Jul 19, 2022

SELL
$4.02 - $10.43 $23,428 - $60,786
-5,828 Reduced 12.18%
42,008 $185,000
Q1 2022

May 04, 2022

SELL
$8.43 - $20.9 $17,745 - $43,994
-2,105 Reduced 4.21%
47,836 $435,000
Q4 2021

Jan 31, 2022

BUY
$19.26 - $30.08 $565,049 - $882,487
29,338 Added 142.4%
49,941 $1.02 Million
Q3 2021

Oct 29, 2021

BUY
$24.86 - $35.02 $92,504 - $130,309
3,721 Added 22.04%
20,603 $526,000
Q2 2021

Aug 11, 2021

BUY
$22.3 - $36.02 $17,572 - $28,383
788 Added 4.9%
16,882 $590,000
Q1 2021

May 04, 2021

BUY
$26.38 - $51.15 $145,775 - $282,654
5,526 Added 52.29%
16,094 $536,000
Q4 2020

Feb 11, 2021

BUY
$10.5 - $28.5 $110,964 - $301,188
10,568 New
10,568 $274,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $396M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.